Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

TherapeuticsMD Inc.

www.therapeuticsmd.com

Latest From Clarus Therapeutics Inc.

Keeping Track: Clarus, Agile and Sunovion Look To Bounce Back From CRLs; FDA To Review Rituximab Biosimilar

The latest drug development news and highlights from our US FDA Performance Tracker.

Drug Review Approvals

Pipeline Watch: Phase III Progress With Anacetrapib, ALKS 3831 And LentiGlobin

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch Approvals

AUA 2016: Studies Suggest Safety Ahead Of Lipocine's Oral Testosterone PDUFA

While Lipocine Inc. is at the nail-biting stage of development for its oral testosterone Tlando (LPCN 1021) – awaiting a US FDA approval decision – urologists continue to study testosterone therapy to determine whether treatment of hypogonadal men is safe with appropriate monitoring.

Companies Clinical Trials

Testosterone Products Need Post-Market Cardiovascular Trial

Labeling updates will also clarify approved uses and warn of possible increased risk of heart attack and stroke; impact on products in development unclear.

BioPharmaceutical Regulation
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Generic Drugs
    • Nutraceuticals
    • OTC, Consumer
  • Therapeutic Areas
  • Gynecological, Urological
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • TherapeuticsMD Inc.
  • Senior Management
  • Robert Finizio, CEO
    Dan Cartwright, CFO
    Dawn Halkuff, Chief Commercial Officer
    Sebastian Mirkin, MD, CMO
    Yulii Bogatyrenko, SVP, Bus. Dev.
  • Contact Info
  • TherapeuticsMD Inc.
    Phone: (561) 961-1900
    6800 Broken Sound Pkwy. NW
    3rd Fl.
    Boca Raton, FL 33487
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register